Table 1 Lysozyme HSCORE values classified according to various characteristics of patients and tumors
From: Expression and prognostic significance of lysozyme in male breast cancer
HSCORE * | ||||
|---|---|---|---|---|
Characteristics | n | Mean ± s.e | Median (range) | P |
Total tumors | 60 | 85.6 ± 13.6 | 0 (0–320) | |
Age | n.s. | |||
<60 | 15 | 85.3 ± 28.8 | 0 (0–270) | |
≥ 60 | 45 | 85.7 ± 15.6 | 0 (0–320) | |
Tumor size | n.s. | |||
T1 | 20 | 77.5 ± 22.7 | 0 (0–270) | |
T2 | 19 | 110 ± 27.3 | 100 (0–320) | |
T3–T4 | 21 | 71.4 ± 21.3 | 0 (0–270) | |
Nodal status | n.s. | |||
N0 | 32 | 89.6 ± 19.7 | 0 (0–320) | |
N+ | 28 | 84.1 ± 19.5 | 0 (0–270) | |
Histological grade | n.s. | |||
I | 12 | 62.5 ± 34 | 0 (0–320) | |
II | 28 | 102.8 ± 20.1 | 110 (0–270) | |
III | 20 | 75.5 ± 21.9 | 0 (0–270) | |
Metastasis status | n.s. | |||
M0 | 57 | 87.7 ± 14.2 | 0 (0–320) | |
M1 | 3 | 46.6 ± 46.6 | 0 (0–140) | |
Estrogen receptor status (fmol/mg protein) | ||||
≥ 10 | 30 | 81.6 ± 18.5 | 0 (0–270) | |
<10 | 3 | 0 | 0 (0) | |
Histological type | n.s. | |||
Ductal | 53 | 93.5 ± 14.8 | 0 (0–320) | |
Lobular | 2 | 0 | 0 (0) | |
Papillary | 3 | 60 ± 60 | 0 (0–180) | |
Cribiform | 2 | 0 | 0 (0) | |